This drug entry is a stub and has not been fully annotated. It is scheduled to be annotated soon.

Identification

Name
Raclopride
Accession Number
DB12518
Type
Small Molecule
Groups
Investigational
Description

Raclopride has been used in trials studying Parkinson Disease.

Structure
Thumb
Synonyms
Not Available
Categories
UNII
430K3SOZ7G
CAS number
84225-95-6
Weight
Average: 347.24
Monoisotopic: 346.0850979
Chemical Formula
C15H20Cl2N2O3
InChI Key
WAOQONBSWFLFPE-VIFPVBQESA-N
InChI
InChI=1S/C15H20Cl2N2O3/c1-3-19-6-4-5-9(19)8-18-15(21)12-13(20)10(16)7-11(17)14(12)22-2/h7,9,20H,3-6,8H2,1-2H3,(H,18,21)/t9-/m0/s1
IUPAC Name
3,5-dichloro-N-{[(2S)-1-ethylpyrrolidin-2-yl]methyl}-2-hydroxy-6-methoxybenzene-1-carboximidic acid
SMILES
[H][[email protected]@]1(CN=C(O)C2=C(O)C(Cl)=CC(Cl)=C2OC)CCCN1CC

Pharmacology

Indication
Not Available
Structured Indications
Not Available
Pharmacodynamics
Not Available
Mechanism of action
TargetActionsOrganism
UD(2) dopamine receptor
antagonist
Human
Absorption
Not Available
Volume of distribution
Not Available
Protein binding
Not Available
Metabolism
Not Available
Route of elimination
Not Available
Half life
Not Available
Clearance
Not Available
Toxicity
Not Available
Affected organisms
Not Available
Pathways
Not Available
Pharmacogenomic Effects/ADRs
Not Available

Interactions

Drug Interactions
DrugInteractionDrug group
2,5-Dimethoxy-4-ethylamphetamineRaclopride may decrease the stimulatory activities of 2,5-Dimethoxy-4-ethylamphetamine.Experimental, Illicit
3,4-MethylenedioxyamphetamineRaclopride may decrease the stimulatory activities of 3,4-Methylenedioxyamphetamine.Experimental, Illicit
4-Bromo-2,5-dimethoxyamphetamineRaclopride may decrease the stimulatory activities of 4-Bromo-2,5-dimethoxyamphetamine.Experimental, Illicit
7-NitroindazoleThe risk or severity of adverse effects can be increased when 7-Nitroindazole is combined with Raclopride.Experimental
AcepromazineThe risk or severity of adverse effects can be increased when Acepromazine is combined with Raclopride.Approved, Vet Approved
AceprometazineThe risk or severity of adverse effects can be increased when Aceprometazine is combined with Raclopride.Approved
AdipiplonThe risk or severity of adverse effects can be increased when Adipiplon is combined with Raclopride.Investigational
AgomelatineThe risk or severity of adverse effects can be increased when Agomelatine is combined with Raclopride.Approved, Investigational
AlaproclateThe risk or severity of adverse effects can be increased when Raclopride is combined with Alaproclate.Experimental
AlfaxaloneThe risk or severity of adverse effects can be increased when Alfaxalone is combined with Raclopride.Vet Approved
AlfentanilThe risk or severity of adverse effects can be increased when Alfentanil is combined with Raclopride.Approved, Illicit
AllopregnanoloneThe risk or severity of adverse effects can be increased when Allopregnanolone is combined with Raclopride.Investigational
AlmotriptanThe risk or severity of adverse effects can be increased when Almotriptan is combined with Raclopride.Approved, Investigational
AlphacetylmethadolThe risk or severity of adverse effects can be increased when Alphacetylmethadol is combined with Raclopride.Experimental, Illicit
AlphaprodineThe risk or severity of adverse effects can be increased when Raclopride is combined with Alphaprodine.Illicit
AlprazolamThe risk or severity of adverse effects can be increased when Alprazolam is combined with Raclopride.Approved, Illicit, Investigational
AmisulprideThe risk or severity of adverse effects can be increased when Raclopride is combined with Amisulpride.Approved, Investigational
AmitriptylineThe risk or severity of adverse effects can be increased when Raclopride is combined with Amitriptyline.Approved
AmobarbitalThe risk or severity of adverse effects can be increased when Amobarbital is combined with Raclopride.Approved, Illicit
AmoxapineThe risk or severity of adverse effects can be increased when Raclopride is combined with Amoxapine.Approved
AmperozideThe risk or severity of adverse effects can be increased when Amperozide is combined with Raclopride.Experimental
AmphetamineRaclopride may decrease the stimulatory activities of Amphetamine.Approved, Illicit
AripiprazoleThe risk or severity of adverse effects can be increased when Aripiprazole is combined with Raclopride.Approved, Investigational
ArticaineThe risk or severity of adverse effects can be increased when Articaine is combined with Raclopride.Approved
AsenapineThe risk or severity of adverse effects can be increased when Asenapine is combined with Raclopride.Approved
AzaperoneThe risk or severity of adverse effects can be increased when Azaperone is combined with Raclopride.Vet Approved
AzelastineRaclopride may increase the central nervous system depressant (CNS depressant) activities of Azelastine.Approved
BaclofenThe risk or severity of adverse effects can be increased when Raclopride is combined with Baclofen.Approved
BarbitalThe risk or severity of adverse effects can be increased when Barbital is combined with Raclopride.Illicit
BenperidolThe risk or severity of adverse effects can be increased when Raclopride is combined with Benperidol.Investigational
BenzocaineThe risk or severity of adverse effects can be increased when Benzocaine is combined with Raclopride.Approved
BenzphetamineRaclopride may decrease the stimulatory activities of Benzphetamine.Approved, Illicit
Benzyl alcoholThe risk or severity of adverse effects can be increased when Benzyl alcohol is combined with Raclopride.Approved
BrexpiprazoleThe risk or severity of adverse effects can be increased when Raclopride is combined with Brexpiprazole.Approved
BrimonidineBrimonidine may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved
BromazepamThe risk or severity of adverse effects can be increased when Bromazepam is combined with Raclopride.Approved, Illicit
BromisovalThe risk or severity of adverse effects can be increased when Raclopride is combined with Bromisoval.Experimental
BromocriptineThe risk or severity of adverse effects can be increased when Bromocriptine is combined with Raclopride.Approved, Investigational
BromperidolThe risk or severity of adverse effects can be increased when Bromperidol is combined with Raclopride.Investigational
BrompheniramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Brompheniramine.Approved
BrotizolamThe risk or severity of adverse effects can be increased when Brotizolam is combined with Raclopride.Approved, Withdrawn
BupivacaineThe risk or severity of adverse effects can be increased when Bupivacaine is combined with Raclopride.Approved, Investigational
BuprenorphineRaclopride may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine.Approved, Illicit, Investigational, Vet Approved
BuspironeThe risk or severity of adverse effects can be increased when Buspirone is combined with Raclopride.Approved, Investigational
ButabarbitalThe risk or severity of adverse effects can be increased when Butabarbital is combined with Raclopride.Approved, Illicit
ButacaineThe risk or severity of adverse effects can be increased when Butacaine is combined with Raclopride.Vet Approved
ButalbitalThe risk or severity of adverse effects can be increased when Raclopride is combined with Butalbital.Approved, Illicit
ButambenThe risk or severity of adverse effects can be increased when Butamben is combined with Raclopride.Approved
ButethalThe risk or severity of adverse effects can be increased when Butethal is combined with Raclopride.Approved, Illicit
ButorphanolThe risk or severity of adverse effects can be increased when Butorphanol is combined with Raclopride.Approved, Illicit, Vet Approved
CabergolineThe risk or severity of adverse effects can be increased when Cabergoline is combined with Raclopride.Approved
CanertinibThe risk or severity of adverse effects can be increased when Canertinib is combined with Raclopride.Investigational
CarbamazepineThe risk or severity of adverse effects can be increased when Carbamazepine is combined with Raclopride.Approved, Investigational
CarbinoxamineThe risk or severity of adverse effects can be increased when Raclopride is combined with Carbinoxamine.Approved
CarfentanilThe risk or severity of adverse effects can be increased when Carfentanil is combined with Raclopride.Illicit, Vet Approved
CarisoprodolThe risk or severity of adverse effects can be increased when Raclopride is combined with Carisoprodol.Approved
CetirizineThe risk or severity of adverse effects can be increased when Raclopride is combined with Cetirizine.Approved
Chloral hydrateThe risk or severity of adverse effects can be increased when Chloral hydrate is combined with Raclopride.Approved, Illicit, Vet Approved
ChlordiazepoxideThe risk or severity of adverse effects can be increased when Chlordiazepoxide is combined with Raclopride.Approved, Illicit
ChlormezanoneThe risk or severity of adverse effects can be increased when Chlormezanone is combined with Raclopride.Approved, Withdrawn
ChloroprocaineThe risk or severity of adverse effects can be increased when Chloroprocaine is combined with Raclopride.Approved
ChlorphenamineThe risk or severity of adverse effects can be increased when Raclopride is combined with Chlorphenamine.Approved
ChlorphentermineRaclopride may decrease the stimulatory activities of Chlorphentermine.Illicit, Withdrawn
ChlorpromazineThe risk or severity of adverse effects can be increased when Chlorpromazine is combined with Raclopride.Approved, Vet Approved
ChlorprothixeneThe risk or severity of adverse effects can be increased when Chlorprothixene is combined with Raclopride.Approved, Withdrawn
ChlorzoxazoneThe risk or severity of adverse effects can be increased when Raclopride is combined with Chlorzoxazone.Approved
CinchocaineThe risk or severity of adverse effects can be increased when Cinchocaine is combined with Raclopride.Approved, Vet Approved
CitalopramThe risk or severity of adverse effects can be increased when Citalopram is combined with Raclopride.Approved
ClemastineThe risk or severity of adverse effects can be increased when Raclopride is combined with Clemastine.Approved
ClidiniumThe risk or severity of adverse effects can be increased when Raclopride is combined with Clidinium.Approved
ClobazamThe risk or severity of adverse effects can be increased when Raclopride is combined with Clobazam.Approved, Illicit
clomethiazoleThe risk or severity of adverse effects can be increased when clomethiazole is combined with Raclopride.Investigational
ClomipramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Clomipramine.Approved, Vet Approved
ClonazepamThe risk or severity of adverse effects can be increased when Raclopride is combined with Clonazepam.Approved, Illicit
ClonidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Clonidine.Approved
ClopenthixolThe risk or severity of adverse effects can be increased when Raclopride is combined with Clopenthixol.Experimental
ClorazepateThe risk or severity of adverse effects can be increased when Clorazepate is combined with Raclopride.Approved, Illicit
ClothiapineThe risk or severity of adverse effects can be increased when Raclopride is combined with Clothiapine.Experimental
ClozapineThe risk or severity of adverse effects can be increased when Clozapine is combined with Raclopride.Approved
CocaineThe risk or severity of adverse effects can be increased when Cocaine is combined with Raclopride.Approved, Illicit
CodeineThe risk or severity of adverse effects can be increased when Codeine is combined with Raclopride.Approved, Illicit
CyclizineThe risk or severity of adverse effects can be increased when Raclopride is combined with Cyclizine.Approved
CyclobenzaprineThe risk or severity of adverse effects can be increased when Cyclobenzaprine is combined with Raclopride.Approved
CyproheptadineThe risk or severity of adverse effects can be increased when Raclopride is combined with Cyproheptadine.Approved
DantroleneThe risk or severity of adverse effects can be increased when Raclopride is combined with Dantrolene.Approved
DapiprazoleThe risk or severity of adverse effects can be increased when Dapiprazole is combined with Raclopride.Approved
DapoxetineThe risk or severity of adverse effects can be increased when Raclopride is combined with Dapoxetine.Investigational
DeramciclaneThe risk or severity of adverse effects can be increased when Deramciclane is combined with Raclopride.Investigational
DesfluraneThe risk or severity of adverse effects can be increased when Desflurane is combined with Raclopride.Approved
DesipramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Desipramine.Approved
DesloratadineThe risk or severity of adverse effects can be increased when Raclopride is combined with Desloratadine.Approved, Investigational
DesvenlafaxineThe risk or severity of adverse effects can be increased when Desvenlafaxine is combined with Raclopride.Approved
DetomidineThe risk or severity of adverse effects can be increased when Detomidine is combined with Raclopride.Vet Approved
DexbrompheniramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Dexbrompheniramine.Approved
DexmedetomidineThe risk or severity of adverse effects can be increased when Dexmedetomidine is combined with Raclopride.Approved, Vet Approved
DextroamphetamineRaclopride may decrease the stimulatory activities of Dextroamphetamine.Approved, Illicit
DextromethorphanThe risk or severity of adverse effects can be increased when Dextromethorphan is combined with Raclopride.Approved
DextromoramideThe risk or severity of adverse effects can be increased when Dextromoramide is combined with Raclopride.Experimental, Illicit
DextropropoxypheneThe risk or severity of adverse effects can be increased when Dextropropoxyphene is combined with Raclopride.Approved, Illicit, Withdrawn
DezocineThe risk or severity of adverse effects can be increased when Dezocine is combined with Raclopride.Approved
DiazepamThe risk or severity of adverse effects can be increased when Diazepam is combined with Raclopride.Approved, Illicit, Vet Approved
Diethyl etherThe risk or severity of adverse effects can be increased when Raclopride is combined with Diethyl ether.Experimental
DiethylpropionRaclopride may decrease the stimulatory activities of Diethylpropion.Approved, Illicit
DifenoxinThe risk or severity of adverse effects can be increased when Raclopride is combined with Difenoxin.Approved, Illicit
DihydrocodeineThe risk or severity of adverse effects can be increased when Dihydrocodeine is combined with Raclopride.Approved, Illicit
DihydroergotamineThe risk or severity of adverse effects can be increased when Dihydroergotamine is combined with Raclopride.Approved
DihydroetorphineThe risk or severity of adverse effects can be increased when Dihydroetorphine is combined with Raclopride.Experimental, Illicit
DihydromorphineThe risk or severity of adverse effects can be increased when Dihydromorphine is combined with Raclopride.Experimental, Illicit
DimenhydrinateThe risk or severity of adverse effects can be increased when Raclopride is combined with Dimenhydrinate.Approved
DiphenhydramineThe risk or severity of adverse effects can be increased when Diphenhydramine is combined with Raclopride.Approved
DiphenoxylateThe risk or severity of adverse effects can be increased when Diphenoxylate is combined with Raclopride.Approved, Illicit
DixyrazineThe risk or severity of adverse effects can be increased when Raclopride is combined with Dixyrazine.Experimental
DoramectinThe risk or severity of adverse effects can be increased when Doramectin is combined with Raclopride.Vet Approved
DoxepinThe risk or severity of adverse effects can be increased when Raclopride is combined with Doxepin.Approved
DoxylamineDoxylamine may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Vet Approved
DPDPEThe risk or severity of adverse effects can be increased when DPDPE is combined with Raclopride.Investigational
DronabinolDronabinol may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Illicit
DroperidolDroperidol may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Vet Approved
DrotebanolThe risk or severity of adverse effects can be increased when Drotebanol is combined with Raclopride.Experimental, Illicit
DuloxetineThe risk or severity of adverse effects can be increased when Duloxetine is combined with Raclopride.Approved
DyclonineThe risk or severity of adverse effects can be increased when Dyclonine is combined with Raclopride.Approved
EcgonineThe risk or severity of adverse effects can be increased when Ecgonine is combined with Raclopride.Experimental, Illicit
EcopipamThe risk or severity of adverse effects can be increased when Ecopipam is combined with Raclopride.Investigational
EfavirenzThe risk or severity of adverse effects can be increased when Raclopride is combined with Efavirenz.Approved, Investigational
EletriptanThe risk or severity of adverse effects can be increased when Eletriptan is combined with Raclopride.Approved, Investigational
EltanoloneThe risk or severity of adverse effects can be increased when Eltanolone is combined with Raclopride.Investigational
EnfluraneThe risk or severity of adverse effects can be increased when Enflurane is combined with Raclopride.Approved, Vet Approved
EntacaponeThe risk or severity of adverse effects can be increased when Raclopride is combined with Entacapone.Approved, Investigational
Ergoloid mesylateThe risk or severity of adverse effects can be increased when Ergoloid mesylate is combined with Raclopride.Approved
ErgonovineThe risk or severity of adverse effects can be increased when Ergonovine is combined with Raclopride.Approved
ErgotamineThe risk or severity of adverse effects can be increased when Ergotamine is combined with Raclopride.Approved
EscitalopramThe risk or severity of adverse effects can be increased when Escitalopram is combined with Raclopride.Approved, Investigational
EstazolamThe risk or severity of adverse effects can be increased when Estazolam is combined with Raclopride.Approved, Illicit
EszopicloneThe risk or severity of adverse effects can be increased when Eszopiclone is combined with Raclopride.Approved
EthanolRaclopride may increase the central nervous system depressant (CNS depressant) activities of Ethanol.Approved
EthchlorvynolThe risk or severity of adverse effects can be increased when Ethchlorvynol is combined with Raclopride.Approved, Illicit, Withdrawn
EthosuximideThe risk or severity of adverse effects can be increased when Raclopride is combined with Ethosuximide.Approved
EthotoinThe risk or severity of adverse effects can be increased when Raclopride is combined with Ethotoin.Approved
Ethyl carbamateThe risk or severity of adverse effects can be increased when Ethyl carbamate is combined with Raclopride.Withdrawn
Ethyl chlorideThe risk or severity of adverse effects can be increased when Raclopride is combined with Ethyl chloride.Experimental
Ethyl loflazepateThe risk or severity of adverse effects can be increased when Ethyl loflazepate is combined with Raclopride.Approved, Illicit
EthylmorphineThe risk or severity of adverse effects can be increased when Ethylmorphine is combined with Raclopride.Approved, Illicit
EtidocaineThe risk or severity of adverse effects can be increased when Etidocaine is combined with Raclopride.Approved
EtifoxineThe risk or severity of adverse effects can be increased when Etifoxine is combined with Raclopride.Withdrawn
EtizolamThe risk or severity of adverse effects can be increased when Etizolam is combined with Raclopride.Approved
EtomidateThe risk or severity of adverse effects can be increased when Etomidate is combined with Raclopride.Approved
EtoperidoneThe risk or severity of adverse effects can be increased when Raclopride is combined with Etoperidone.Approved
EtorphineThe risk or severity of adverse effects can be increased when Etorphine is combined with Raclopride.Illicit, Vet Approved
EzogabineThe risk or severity of adverse effects can be increased when Raclopride is combined with Ezogabine.Approved
FelbamateThe risk or severity of adverse effects can be increased when Raclopride is combined with Felbamate.Approved
FencamfamineThe risk or severity of adverse effects can be increased when Fencamfamine is combined with Raclopride.Approved, Illicit, Withdrawn
FentanylThe risk or severity of adverse effects can be increased when Fentanyl is combined with Raclopride.Approved, Illicit, Investigational, Vet Approved
FexofenadineThe risk or severity of adverse effects can be increased when Raclopride is combined with Fexofenadine.Approved
FlibanserinThe risk or severity of adverse effects can be increased when Raclopride is combined with Flibanserin.Approved
FluanisoneThe risk or severity of adverse effects can be increased when Raclopride is combined with Fluanisone.Experimental
FludiazepamThe risk or severity of adverse effects can be increased when Fludiazepam is combined with Raclopride.Approved, Illicit
FlunarizineThe risk or severity of adverse effects can be increased when Raclopride is combined with Flunarizine.Approved
FlunitrazepamThe risk or severity of adverse effects can be increased when Flunitrazepam is combined with Raclopride.Approved, Illicit
FluoxetineThe risk or severity of adverse effects can be increased when Fluoxetine is combined with Raclopride.Approved, Vet Approved
FlupentixolThe risk or severity of adverse effects can be increased when Flupentixol is combined with Raclopride.Approved, Withdrawn
FluphenazineThe risk or severity of adverse effects can be increased when Fluphenazine is combined with Raclopride.Approved
FlurazepamThe risk or severity of adverse effects can be increased when Flurazepam is combined with Raclopride.Approved, Illicit
FluspirileneThe risk or severity of adverse effects can be increased when Fluspirilene is combined with Raclopride.Approved
Fluticasone propionateThe risk or severity of adverse effects can be increased when Raclopride is combined with Fluticasone propionate.Approved
FluvoxamineThe risk or severity of adverse effects can be increased when Fluvoxamine is combined with Raclopride.Approved, Investigational
FosphenytoinThe risk or severity of adverse effects can be increased when Raclopride is combined with Fosphenytoin.Approved
FospropofolThe risk or severity of adverse effects can be increased when Fospropofol is combined with Raclopride.Approved, Illicit
FrovatriptanThe risk or severity of adverse effects can be increased when Frovatriptan is combined with Raclopride.Approved, Investigational
GabapentinThe risk or severity of adverse effects can be increased when Gabapentin is combined with Raclopride.Approved, Investigational
Gabapentin EnacarbilThe risk or severity of adverse effects can be increased when Raclopride is combined with Gabapentin Enacarbil.Approved
Gamma Hydroxybutyric AcidThe risk or severity of adverse effects can be increased when Gamma Hydroxybutyric Acid is combined with Raclopride.Approved, Illicit
GepefrineRaclopride may decrease the stimulatory activities of Gepefrine.Experimental
GepironeThe risk or severity of adverse effects can be increased when Gepirone is combined with Raclopride.Investigational
GlutethimideThe risk or severity of adverse effects can be increased when Glutethimide is combined with Raclopride.Approved, Illicit
GuanfacineThe risk or severity of adverse effects can be increased when Raclopride is combined with Guanfacine.Approved, Investigational
HalazepamThe risk or severity of adverse effects can be increased when Halazepam is combined with Raclopride.Approved, Illicit, Withdrawn
HaloperidolThe risk or severity of adverse effects can be increased when Haloperidol is combined with Raclopride.Approved
HalothaneThe risk or severity of adverse effects can be increased when Halothane is combined with Raclopride.Approved, Vet Approved
HeroinThe risk or severity of adverse effects can be increased when Heroin is combined with Raclopride.Approved, Illicit
HexobarbitalThe risk or severity of adverse effects can be increased when Hexobarbital is combined with Raclopride.Approved
HydrocodoneRaclopride may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone.Approved, Illicit
HydromorphoneThe risk or severity of adverse effects can be increased when Hydromorphone is combined with Raclopride.Approved, Illicit
HydroxyamphetamineRaclopride may decrease the stimulatory activities of Hydroxyamphetamine.Approved
HydroxyzineHydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved
IloperidoneThe risk or severity of adverse effects can be increased when Raclopride is combined with Iloperidone.Approved
ImipramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Imipramine.Approved
IndalpineThe risk or severity of adverse effects can be increased when Raclopride is combined with Indalpine.Investigational, Withdrawn
IndiplonThe risk or severity of adverse effects can be increased when Raclopride is combined with Indiplon.Investigational
Iofetamine I-123Raclopride may decrease the stimulatory activities of Iofetamine I-123.Approved
IsocarboxazidThe risk or severity of adverse effects can be increased when Isocarboxazid is combined with Raclopride.Approved
IsofluraneThe risk or severity of adverse effects can be increased when Isoflurane is combined with Raclopride.Approved, Vet Approved
KetamineThe risk or severity of adverse effects can be increased when Ketamine is combined with Raclopride.Approved, Vet Approved
KetazolamThe risk or severity of adverse effects can be increased when Ketazolam is combined with Raclopride.Approved
KetobemidoneThe risk or severity of adverse effects can be increased when Ketobemidone is combined with Raclopride.Approved
LamotrigineThe risk or severity of adverse effects can be increased when Raclopride is combined with Lamotrigine.Approved, Investigational
LevetiracetamThe risk or severity of adverse effects can be increased when Raclopride is combined with Levetiracetam.Approved, Investigational
LevobupivacaineThe risk or severity of adverse effects can be increased when Levobupivacaine is combined with Raclopride.Approved
LevocabastineThe risk or severity of adverse effects can be increased when Raclopride is combined with Levocabastine.Approved
LevocetirizineThe risk or severity of adverse effects can be increased when Raclopride is combined with Levocetirizine.Approved
LevodopaThe risk or severity of adverse effects can be increased when Raclopride is combined with Levodopa.Approved
Levomethadyl AcetateThe risk or severity of adverse effects can be increased when Levomethadyl Acetate is combined with Raclopride.Approved
LevomilnacipranThe risk or severity of adverse effects can be increased when Levomilnacipran is combined with Raclopride.Approved
LevorphanolThe risk or severity of adverse effects can be increased when Levorphanol is combined with Raclopride.Approved
LidocaineThe risk or severity of adverse effects can be increased when Lidocaine is combined with Raclopride.Approved, Vet Approved
LinezolidThe risk or severity of adverse effects can be increased when Linezolid is combined with Raclopride.Approved, Investigational
LisdexamfetamineRaclopride may decrease the stimulatory activities of Lisdexamfetamine.Approved, Investigational
LithiumLithium may increase the neurotoxic activities of Raclopride.Approved
LofentanilThe risk or severity of adverse effects can be increased when Lofentanil is combined with Raclopride.Illicit
LoprazolamThe risk or severity of adverse effects can be increased when Raclopride is combined with Loprazolam.Experimental
LoratadineThe risk or severity of adverse effects can be increased when Raclopride is combined with Loratadine.Approved
LorazepamThe risk or severity of adverse effects can be increased when Lorazepam is combined with Raclopride.Approved
LorcaserinThe risk or severity of adverse effects can be increased when Lorcaserin is combined with Raclopride.Approved
LormetazepamThe risk or severity of adverse effects can be increased when Raclopride is combined with Lormetazepam.Approved
LoxapineThe risk or severity of adverse effects can be increased when Loxapine is combined with Raclopride.Approved
LurasidoneThe risk or severity of adverse effects can be increased when Lurasidone is combined with Raclopride.Approved
Magnesium SulfateMagnesium Sulfate may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Vet Approved
MaprotilineThe risk or severity of adverse effects can be increased when Raclopride is combined with Maprotiline.Approved
MebicarThe risk or severity of adverse effects can be increased when Raclopride is combined with Mebicar.Experimental
MeclizineThe risk or severity of adverse effects can be increased when Raclopride is combined with Meclizine.Approved
MedazepamThe risk or severity of adverse effects can be increased when Raclopride is combined with Medazepam.Experimental
MedetomidineThe risk or severity of adverse effects can be increased when Medetomidine is combined with Raclopride.Vet Approved
MelatoninThe risk or severity of adverse effects can be increased when Melatonin is combined with Raclopride.Approved, Nutraceutical, Vet Approved
MelperoneThe risk or severity of adverse effects can be increased when Melperone is combined with Raclopride.Approved
MephedroneRaclopride may decrease the stimulatory activities of Mephedrone.Investigational
MephentermineRaclopride may decrease the stimulatory activities of Mephentermine.Approved
MepivacaineThe risk or severity of adverse effects can be increased when Mepivacaine is combined with Raclopride.Approved, Vet Approved
MeprobamateThe risk or severity of adverse effects can be increased when Meprobamate is combined with Raclopride.Approved, Illicit
MeptazinolThe risk or severity of adverse effects can be increased when Raclopride is combined with Meptazinol.Experimental
MequitazineRaclopride may increase the arrhythmogenic activities of Mequitazine.Approved
MesoridazineThe risk or severity of adverse effects can be increased when Mesoridazine is combined with Raclopride.Approved
MetaxaloneThe risk or severity of adverse effects can be increased when Raclopride is combined with Metaxalone.Approved
MethadoneThe risk or severity of adverse effects can be increased when Methadone is combined with Raclopride.Approved
Methadyl AcetateThe risk or severity of adverse effects can be increased when Methadyl Acetate is combined with Raclopride.Approved, Illicit
MethamphetamineRaclopride may decrease the stimulatory activities of Methamphetamine.Approved, Illicit
MethapyrileneThe risk or severity of adverse effects can be increased when Methapyrilene is combined with Raclopride.Withdrawn
MethaqualoneThe risk or severity of adverse effects can be increased when Methaqualone is combined with Raclopride.Illicit, Withdrawn
MethocarbamolThe risk or severity of adverse effects can be increased when Raclopride is combined with Methocarbamol.Approved, Vet Approved
MethohexitalThe risk or severity of adverse effects can be increased when Methohexital is combined with Raclopride.Approved
MethotrimeprazineRaclopride may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine.Approved
MethoxyfluraneThe risk or severity of adverse effects can be increased when Methoxyflurane is combined with Raclopride.Approved, Vet Approved
MethoxyphenamineRaclopride may decrease the stimulatory activities of Methoxyphenamine.Experimental
MethsuximideThe risk or severity of adverse effects can be increased when Raclopride is combined with Methsuximide.Approved
MethylecgonineThe risk or severity of adverse effects can be increased when Methylecgonine is combined with Raclopride.Experimental
MethylphenidateThe risk or severity of adverse effects can be increased when Raclopride is combined with Methylphenidate.Approved, Investigational
MethylphenobarbitalThe risk or severity of adverse effects can be increased when Methylphenobarbital is combined with Raclopride.Approved
MetoclopramideThe risk or severity of adverse effects can be increased when Metoclopramide is combined with Raclopride.Approved, Investigational
MetyrosineRaclopride may increase the sedative activities of Metyrosine.Approved
MidazolamThe risk or severity of adverse effects can be increased when Midazolam is combined with Raclopride.Approved, Illicit
MidomafetamineRaclopride may decrease the stimulatory activities of 3,4-Methylenedioxymethamphetamine.Experimental, Illicit
MilnacipranThe risk or severity of adverse effects can be increased when Milnacipran is combined with Raclopride.Approved
MinocyclineMinocycline may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Investigational
MirtazapineRaclopride may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine.Approved
MMDARaclopride may decrease the stimulatory activities of MMDA.Experimental, Illicit
MoclobemideThe risk or severity of adverse effects can be increased when Moclobemide is combined with Raclopride.Approved
MolindoneThe risk or severity of adverse effects can be increased when Molindone is combined with Raclopride.Approved
MorphineThe risk or severity of adverse effects can be increased when Morphine is combined with Raclopride.Approved, Investigational
NabiloneNabilone may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved, Investigational
NalbuphineThe risk or severity of adverse effects can be increased when Nalbuphine is combined with Raclopride.Approved
NaratriptanThe risk or severity of adverse effects can be increased when Naratriptan is combined with Raclopride.Approved, Investigational
NefazodoneThe risk or severity of adverse effects can be increased when Nefazodone is combined with Raclopride.Approved, Withdrawn
NitrazepamThe risk or severity of adverse effects can be increased when Nitrazepam is combined with Raclopride.Approved
Nitrous oxideThe risk or severity of adverse effects can be increased when Nitrous oxide is combined with Raclopride.Approved, Vet Approved
NorfluraneThe risk or severity of adverse effects can be increased when Raclopride is combined with Norflurane.Investigational
NormethadoneThe risk or severity of adverse effects can be increased when Normethadone is combined with Raclopride.Approved, Illicit
NortriptylineThe risk or severity of adverse effects can be increased when Raclopride is combined with Nortriptyline.Approved
OlanzapineThe risk or severity of adverse effects can be increased when Olanzapine is combined with Raclopride.Approved, Investigational
OlopatadineThe risk or severity of adverse effects can be increased when Raclopride is combined with Olopatadine.Approved
OndansetronThe risk or severity of adverse effects can be increased when Ondansetron is combined with Raclopride.Approved
OpiumThe risk or severity of adverse effects can be increased when Opium is combined with Raclopride.Approved, Illicit
OrphenadrineRaclopride may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine.Approved
OsanetantThe risk or severity of adverse effects can be increased when Osanetant is combined with Raclopride.Investigational
OxazepamThe risk or severity of adverse effects can be increased when Oxazepam is combined with Raclopride.Approved
OxethazaineThe risk or severity of adverse effects can be increased when Raclopride is combined with Oxethazaine.Investigational
OxprenololThe risk or severity of adverse effects can be increased when Oxprenolol is combined with Raclopride.Approved
OxybuprocaineThe risk or severity of adverse effects can be increased when Oxybuprocaine is combined with Raclopride.Approved
OxycodoneThe risk or severity of adverse effects can be increased when Oxycodone is combined with Raclopride.Approved, Illicit, Investigational
OxymorphoneThe risk or severity of adverse effects can be increased when Oxymorphone is combined with Raclopride.Approved, Investigational, Vet Approved
PaliperidoneThe risk or severity of adverse effects can be increased when Paliperidone is combined with Raclopride.Approved
ParaldehydeRaclopride may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde.Approved
ParoxetineThe risk or severity of adverse effects can be increased when Paroxetine is combined with Raclopride.Approved, Investigational
PenfluridolThe risk or severity of adverse effects can be increased when Raclopride is combined with Penfluridol.Experimental
PentazocineThe risk or severity of adverse effects can be increased when Pentazocine is combined with Raclopride.Approved, Vet Approved
PentobarbitalThe risk or severity of adverse effects can be increased when Pentobarbital is combined with Raclopride.Approved, Vet Approved
PerampanelPerampanel may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved
PerazineThe risk or severity of adverse effects can be increased when Raclopride is combined with Perazine.Investigational
PerospironeThe risk or severity of adverse effects can be increased when Perospirone is combined with Raclopride.Approved
PerphenazineThe risk or severity of adverse effects can be increased when Perphenazine is combined with Raclopride.Approved
PethidineThe risk or severity of adverse effects can be increased when Pethidine is combined with Raclopride.Approved
PhenazocineThe risk or severity of adverse effects can be increased when Raclopride is combined with Phenazocine.Experimental
PhenelzineThe risk or severity of adverse effects can be increased when Phenelzine is combined with Raclopride.Approved
PhenibutThe risk or severity of adverse effects can be increased when Raclopride is combined with Phenibut.Experimental
PhenobarbitalThe risk or severity of adverse effects can be increased when Phenobarbital is combined with Raclopride.Approved
PhenoperidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Phenoperidine.Experimental
PhenoxyethanolThe risk or severity of adverse effects can be increased when Phenoxyethanol is combined with Raclopride.Approved
PhentermineRaclopride may decrease the stimulatory activities of Phentermine.Approved, Illicit
PhenytoinThe risk or severity of adverse effects can be increased when Raclopride is combined with Phenytoin.Approved, Vet Approved
PimozideThe risk or severity of adverse effects can be increased when Pimozide is combined with Raclopride.Approved
PipamperoneThe risk or severity of adverse effects can be increased when Pipamperone is combined with Raclopride.Approved
PipotiazineThe risk or severity of adverse effects can be increased when Raclopride is combined with Pipotiazine.Approved
PiritramideThe risk or severity of adverse effects can be increased when Piritramide is combined with Raclopride.Investigational
PizotifenThe risk or severity of adverse effects can be increased when Raclopride is combined with Pizotifen.Approved
PomalidomideThe risk or severity of adverse effects can be increased when Raclopride is combined with Pomalidomide.Approved
PramipexoleRaclopride may increase the sedative activities of Pramipexole.Approved, Investigational
PramocaineThe risk or severity of adverse effects can be increased when Pramocaine is combined with Raclopride.Approved
PrazepamThe risk or severity of adverse effects can be increased when Prazepam is combined with Raclopride.Approved, Illicit
PregabalinThe risk or severity of adverse effects can be increased when Pregabalin is combined with Raclopride.Approved, Illicit, Investigational
PrilocaineThe risk or severity of adverse effects can be increased when Prilocaine is combined with Raclopride.Approved
PrimidoneThe risk or severity of adverse effects can be increased when Raclopride is combined with Primidone.Approved, Vet Approved
ProcaineThe risk or severity of adverse effects can be increased when Procaine is combined with Raclopride.Approved, Investigational, Vet Approved
ProcarbazineThe risk or severity of adverse effects can be increased when Procarbazine is combined with Raclopride.Approved
ProchlorperazineThe risk or severity of adverse effects can be increased when Prochlorperazine is combined with Raclopride.Approved, Vet Approved
PromazineThe risk or severity of adverse effects can be increased when Promazine is combined with Raclopride.Approved, Vet Approved
PromethazineThe risk or severity of adverse effects can be increased when Raclopride is combined with Promethazine.Approved
PropanididThe risk or severity of adverse effects can be increased when Raclopride is combined with Propanidid.Experimental
ProparacaineThe risk or severity of adverse effects can be increased when Proparacaine is combined with Raclopride.Approved, Vet Approved
PropofolThe risk or severity of adverse effects can be increased when Propofol is combined with Raclopride.Approved, Investigational, Vet Approved
PropoxycaineThe risk or severity of adverse effects can be increased when Propoxycaine is combined with Raclopride.Approved
ProtriptylineThe risk or severity of adverse effects can be increased when Raclopride is combined with Protriptyline.Approved
ProxibarbalThe risk or severity of adverse effects can be increased when Raclopride is combined with Proxibarbal.Experimental
PSD502The risk or severity of adverse effects can be increased when PSD502 is combined with Raclopride.Investigational
PseudoephedrineRaclopride may decrease the stimulatory activities of Pseudoephedrine.Approved
QuazepamThe risk or severity of adverse effects can be increased when Quazepam is combined with Raclopride.Approved, Illicit
QuetiapineThe risk or severity of adverse effects can be increased when Quetiapine is combined with Raclopride.Approved
QuinagolideThe therapeutic efficacy of Quinagolide can be decreased when used in combination with Raclopride.Approved
QuinisocaineThe risk or severity of adverse effects can be increased when Raclopride is combined with Quinisocaine.Experimental
RamelteonThe risk or severity of adverse effects can be increased when Raclopride is combined with Ramelteon.Approved, Investigational
RasagilineThe risk or severity of adverse effects can be increased when Rasagiline is combined with Raclopride.Approved
RemifentanilThe risk or severity of adverse effects can be increased when Remifentanil is combined with Raclopride.Approved
RemoxiprideThe risk or severity of adverse effects can be increased when Remoxipride is combined with Raclopride.Approved, Withdrawn
ReserpineThe risk or severity of adverse effects can be increased when Reserpine is combined with Raclopride.Approved
RisperidoneThe risk or severity of adverse effects can be increased when Risperidone is combined with Raclopride.Approved, Investigational
RitanserinThe risk or severity of adverse effects can be increased when Raclopride is combined with Ritanserin.Investigational
RitobegronRaclopride may decrease the stimulatory activities of Ritobegron.Investigational
RizatriptanThe risk or severity of adverse effects can be increased when Rizatriptan is combined with Raclopride.Approved
RomifidineThe risk or severity of adverse effects can be increased when Romifidine is combined with Raclopride.Vet Approved
RopiniroleRaclopride may increase the sedative activities of Ropinirole.Approved, Investigational
RopivacaineThe risk or severity of adverse effects can be increased when Ropivacaine is combined with Raclopride.Approved
RotigotineRaclopride may increase the sedative activities of Rotigotine.Approved
RufinamideThe risk or severity of adverse effects can be increased when Rufinamide is combined with Raclopride.Approved
ScopolamineThe risk or severity of adverse effects can be increased when Raclopride is combined with Scopolamine.Approved
SecobarbitalThe risk or severity of adverse effects can be increased when Secobarbital is combined with Raclopride.Approved, Vet Approved
SelegilineThe risk or severity of adverse effects can be increased when Selegiline is combined with Raclopride.Approved, Investigational, Vet Approved
SepranoloneThe risk or severity of adverse effects can be increased when Raclopride is combined with Sepranolone.Investigational
SertindoleThe risk or severity of adverse effects can be increased when Sertindole is combined with Raclopride.Approved, Withdrawn
SertralineThe risk or severity of adverse effects can be increased when Sertraline is combined with Raclopride.Approved
SevofluraneThe risk or severity of adverse effects can be increased when Sevoflurane is combined with Raclopride.Approved, Vet Approved
Sodium oxybateSodium oxybate may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved
StiripentolThe risk or severity of adverse effects can be increased when Raclopride is combined with Stiripentol.Approved
SufentanilThe risk or severity of adverse effects can be increased when Sufentanil is combined with Raclopride.Approved, Investigational
SultoprideThe risk or severity of adverse effects can be increased when Raclopride is combined with Sultopride.Experimental
SumatriptanThe risk or severity of adverse effects can be increased when Sumatriptan is combined with Raclopride.Approved, Investigational
SuvorexantRaclopride may increase the central nervous system depressant (CNS depressant) activities of Suvorexant.Approved
TandospironeThe risk or severity of adverse effects can be increased when Raclopride is combined with Tandospirone.Investigational
TapentadolTapentadol may increase the central nervous system depressant (CNS depressant) activities of Raclopride.Approved
TasimelteonThe risk or severity of adverse effects can be increased when Raclopride is combined with Tasimelteon.Approved
Tedizolid PhosphateThe risk or severity of adverse effects can be increased when Tedizolid Phosphate is combined with Raclopride.Approved
TemazepamThe risk or severity of adverse effects can be increased when Temazepam is combined with Raclopride.Approved
TetrabenazineThe risk or severity of adverse effects can be increased when Tetrabenazine is combined with Raclopride.Approved
TetracaineThe risk or severity of adverse effects can be increased when Tetracaine is combined with Raclopride.Approved, Vet Approved
TetrahydropalmatineThe risk or severity of adverse effects can be increased when Tetrahydropalmatine is combined with Raclopride.Investigational
TetrodotoxinThe risk or severity of adverse effects can be increased when Tetrodotoxin is combined with Raclopride.Investigational
ThalidomideRaclopride may increase the central nervous system depressant (CNS depressant) activities of Thalidomide.Approved, Investigational, Withdrawn
ThiamylalThe risk or severity of adverse effects can be increased when Thiamylal is combined with Raclopride.Approved, Vet Approved
ThiopentalThe risk or severity of adverse effects can be increased when Thiopental is combined with Raclopride.Approved, Vet Approved
ThioridazineThe risk or severity of adverse effects can be increased when Thioridazine is combined with Raclopride.Withdrawn
ThiothixeneThe risk or severity of adverse effects can be increased when Thiothixene is combined with Raclopride.Approved
TiagabineThe risk or severity of adverse effects can be increased when Raclopride is combined with Tiagabine.Approved
TiaprideThe risk or severity of adverse effects can be increased when Raclopride is combined with Tiapride.Approved, Investigational
TiletamineThe risk or severity of adverse effects can be increased when Tiletamine is combined with Raclopride.Vet Approved
TilidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Tilidine.Experimental
TizanidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Tizanidine.Approved
TolcaponeThe risk or severity of adverse effects can be increased when Raclopride is combined with Tolcapone.Approved, Withdrawn
TopiramateThe risk or severity of adverse effects can be increased when Raclopride is combined with Topiramate.Approved
TramadolThe risk or severity of adverse effects can be increased when Tramadol is combined with Raclopride.Approved, Investigational
Trans-2-PhenylcyclopropylamineThe risk or severity of adverse effects can be increased when Trans-2-Phenylcyclopropylamine is combined with Raclopride.Experimental
TranylcypromineThe risk or severity of adverse effects can be increased when Tranylcypromine is combined with Raclopride.Approved
TrazodoneThe risk or severity of adverse effects can be increased when Trazodone is combined with Raclopride.Approved, Investigational
TriazolamThe risk or severity of adverse effects can be increased when Triazolam is combined with Raclopride.Approved
Tricaine methanesulfonateThe risk or severity of adverse effects can be increased when Tricaine methanesulfonate is combined with Raclopride.Vet Approved
TrichloroethyleneThe risk or severity of adverse effects can be increased when Raclopride is combined with Trichloroethylene.Experimental
TrifluoperazineThe risk or severity of adverse effects can be increased when Trifluoperazine is combined with Raclopride.Approved
TrifluperidolThe risk or severity of adverse effects can be increased when Raclopride is combined with Trifluperidol.Experimental
TriflupromazineThe risk or severity of adverse effects can be increased when Triflupromazine is combined with Raclopride.Approved, Vet Approved
TrimipramineThe risk or severity of adverse effects can be increased when Raclopride is combined with Trimipramine.Approved
TriprolidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Triprolidine.Approved
Valproic AcidThe risk or severity of adverse effects can be increased when Valproic Acid is combined with Raclopride.Approved, Investigational
VenlafaxineThe risk or severity of adverse effects can be increased when Venlafaxine is combined with Raclopride.Approved
VeraliprideThe risk or severity of adverse effects can be increased when Raclopride is combined with Veralipride.Experimental
VigabatrinThe risk or severity of adverse effects can be increased when Raclopride is combined with Vigabatrin.Approved
VilazodoneThe risk or severity of adverse effects can be increased when Vilazodone is combined with Raclopride.Approved
Vinyl etherThe risk or severity of adverse effects can be increased when Raclopride is combined with Vinyl ether.Experimental
VortioxetineThe risk or severity of adverse effects can be increased when Vortioxetine is combined with Raclopride.Approved
XenonThe risk or severity of adverse effects can be increased when Raclopride is combined with Xenon.Experimental
XylazineThe risk or severity of adverse effects can be increased when Xylazine is combined with Raclopride.Vet Approved
ZaleplonThe risk or severity of adverse effects can be increased when Zaleplon is combined with Raclopride.Approved, Illicit, Investigational
ZiconotideThe risk or severity of adverse effects can be increased when Raclopride is combined with Ziconotide.Approved
ZimelidineThe risk or severity of adverse effects can be increased when Raclopride is combined with Zimelidine.Withdrawn
ZiprasidoneThe risk or severity of adverse effects can be increased when Ziprasidone is combined with Raclopride.Approved
ZolazepamThe risk or severity of adverse effects can be increased when Zolazepam is combined with Raclopride.Vet Approved
ZolmitriptanThe risk or severity of adverse effects can be increased when Zolmitriptan is combined with Raclopride.Approved, Investigational
ZolpidemRaclopride may increase the central nervous system depressant (CNS depressant) activities of Zolpidem.Approved
ZonisamideThe risk or severity of adverse effects can be increased when Raclopride is combined with Zonisamide.Approved, Investigational
ZopicloneThe risk or severity of adverse effects can be increased when Zopiclone is combined with Raclopride.Approved
ZotepineThe risk or severity of adverse effects can be increased when Zotepine is combined with Raclopride.Approved
ZuclopenthixolThe risk or severity of adverse effects can be increased when Zuclopenthixol is combined with Raclopride.Approved, Investigational
Food Interactions
Not Available

References

Synthesis Reference
Not Available
General References
Not Available
External Links
ChemSpider
2298373
BindingDB
50005118
ChEBI
92070
ChEMBL
CHEMBL8809
ATC Codes
Not Available
AHFS Codes
Not Available
PDB Entries
Not Available
FDA label
Not Available
MSDS
Not Available

Clinical Trials

Clinical Trials
PhaseStatusPurposeConditionsCount
1, 2Not Yet RecruitingTreatmentAdhd1
Not AvailableCompletedNot AvailableHealthy Volunteers / Parkinson's Disease (PD)1

Pharmacoeconomics

Manufacturers
Not Available
Packagers
Not Available
Dosage forms
Not Available
Prices
Not Available
Patents
Not Available

Properties

State
Not Available
Experimental Properties
Not Available
Predicted Properties
PropertyValueSource
Water Solubility0.133 mg/mLALOGPS
logP3.38ALOGPS
logP1.82ChemAxon
logS-3.4ALOGPS
pKa (Strongest Acidic)5.31ChemAxon
pKa (Strongest Basic)9.32ChemAxon
Physiological Charge1ChemAxon
Hydrogen Acceptor Count5ChemAxon
Hydrogen Donor Count2ChemAxon
Polar Surface Area65.29 Å2ChemAxon
Rotatable Bond Count5ChemAxon
Refractivity88.59 m3·mol-1ChemAxon
Polarizability35.16 Å3ChemAxon
Number of Rings2ChemAxon
Bioavailability1ChemAxon
Rule of FiveYesChemAxon
Ghose FilterYesChemAxon
Veber's RuleNoChemAxon
MDDR-like RuleNoChemAxon
Predicted ADMET features
Not Available

Spectra

Mass Spec (NIST)
Not Available
Spectra
SpectrumSpectrum TypeSplash Key
Predicted MS/MS Spectrum - 10V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Positive (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 10V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 20V, Negative (Annotated)Predicted LC-MS/MSNot Available
Predicted MS/MS Spectrum - 40V, Negative (Annotated)Predicted LC-MS/MSNot Available
MS/MS Spectrum - , positiveLC-MS/MSsplash10-0002-0119000000-60d7b9266bbc9f46e57c

Taxonomy

Description
This compound belongs to the class of organic compounds known as salicylamides. These are carboxamide derivatives of salicylic acid. Salicylic acid is the ortho-hydroxylated derivative of benzoic acid.
Kingdom
Organic compounds
Super Class
Benzenoids
Class
Benzene and substituted derivatives
Sub Class
Benzoic acids and derivatives
Direct Parent
Salicylamides
Alternative Parents
Methoxyphenols / 3-halobenzoic acids and derivatives / Benzamides / Benzoyl derivatives / Dichlorobenzenes / Anisoles / Methoxybenzenes / O-chlorophenols / P-chlorophenols / Phenoxy compounds
show 12 more
Substituents
Salicylamide / Methoxyphenol / 3-halobenzoic acid or derivatives / Halobenzoic acid or derivatives / Benzamide / Phenol ether / 4-chlorophenol / 2-chlorophenol / Phenoxy compound / 1,3-dichlorobenzene
show 34 more
Molecular Framework
Aromatic heteromonocyclic compounds
External Descriptors
Not Available

Targets

Kind
Protein
Organism
Human
Pharmacological action
Unknown
Actions
Antagonist
General Function
Potassium channel regulator activity
Specific Function
Dopamine receptor whose activity is mediated by G proteins which inhibit adenylyl cyclase.
Gene Name
DRD2
Uniprot ID
P14416
Uniprot Name
D(2) dopamine receptor
Molecular Weight
50618.91 Da
References
  1. Martinez D, Broft A, Foltin RW, Slifstein M, Hwang DR, Huang Y, Perez A, Frankle WG, Cooper T, Kleber HD, Fischman MW, Laruelle M: Cocaine dependence and d2 receptor availability in the functional subdivisions of the striatum: relationship with cocaine-seeking behavior. Neuropsychopharmacology. 2004 Jun;29(6):1190-202. [PubMed:15010698]

Drug created on October 20, 2016 16:41 / Updated on September 01, 2017 12:21